NCT00227279View on ClinicalTrials.gov

A Trial of the ALK Grass Tablet in Subjects With Hayfever

PHASE3CompletedINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Allergy
Interventions
BIOLOGICAL

ALK Grass tablet

Tablets, 75,000 SQ-T or matching placebo. Daily administration for 3 years

Trial Locations (1)

8000

Lungemedicinsk Forskningsafdeling, Aarhus Kommunehospital, Aarhus C

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00227279 - A Trial of the ALK Grass Tablet in Subjects With Hayfever | Biotech Hunter | Biotech Hunter